Gabriel, E., Attwood, K., Du, W., Tuttle, R., Alnaji, R. M., Nurkin, S., . . . Kukar, M. (2016). Association Between Clinically Staged Node-Negative Esophageal Adenocarcinoma and Overall Survival Benefit From Neoadjuvant Chemoradiation. JAMA Surg.
Citação norma ChicagoGabriel, Emmanuel, Kristopher Attwood, William Du, Rebecca Tuttle, Raed M. Alnaji, Steven Nurkin, Usha Malhotra, Steven N. Hochwald, and Moshim Kukar. "Association Between Clinically Staged Node-Negative Esophageal Adenocarcinoma and Overall Survival Benefit From Neoadjuvant Chemoradiation." JAMA Surg 2016.
Citação norma MLAGabriel, Emmanuel, et al. "Association Between Clinically Staged Node-Negative Esophageal Adenocarcinoma and Overall Survival Benefit From Neoadjuvant Chemoradiation." JAMA Surg 2016.